GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 88 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,953,000 | +1.2% | 1,552,740 | +24.4% | 1.60% | +3.3% |
| Q2 2017 | $14,770,000 | +7.0% | 1,248,508 | +15.9% | 1.55% | +2.7% |
| Q1 2017 | $13,810,000 | +31.3% | 1,077,196 | +25.4% | 1.51% | +44.0% |
| Q4 2016 | $10,518,000 | -36.3% | 859,349 | -38.5% | 1.05% | -38.8% |
| Q3 2016 | $16,500,000 | +25.4% | 1,398,288 | -7.6% | 1.71% | +10.0% |
| Q2 2016 | $13,161,000 | +149.2% | 1,512,734 | +50.9% | 1.56% | +137.0% |
| Q1 2016 | $5,282,000 | -44.8% | 1,002,262 | -17.6% | 0.66% | -47.9% |
| Q4 2015 | $9,574,000 | 0.0% | 1,216,481 | 0.0% | 1.26% | +0.8% |
| Q3 2015 | $9,574,000 | – | 1,216,481 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
| Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
| KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
| Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
| PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
| Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
| ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
| PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
| PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
| Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |